Found: 7
Select item for more details and to access through your institution.
The Bromodomain Inhibitor N-Methyl pyrrolidone Prevents Osteoporosis and BMP-Triggered Sclerostin Expression in Osteocytes.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3332, doi. 10.3390/ijms19113332
- By:
- Publication type:
- Article
N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment.
- Published in:
- Scientific Reports, 2017, p. 42108, doi. 10.1038/srep42108
- By:
- Publication type:
- Article
N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling.
- Published in:
- Inflammation Research, 2015, v. 64, n. 7, p. 527, doi. 10.1007/s00011-015-0833-x
- By:
- Publication type:
- Article
The potential of N‐methylpyrrolidone to prevent osteoporosis and enhance bone regeneration in vivo (1139.5).
- Published in:
- FASEB Journal, 2014, v. 28, p. N.PAG, doi. 10.1096/fasebj.28.1_supplement.1139.5
- By:
- Publication type:
- Article
Comparative genome analysis of P seudomonas knackmussii B13, the first bacterium known to degrade chloroaromatic compounds.
- Published in:
- Environmental Microbiology, 2015, v. 17, n. 1, p. 91, doi. 10.1111/1462-2920.12498
- By:
- Publication type:
- Article
Comparative study of NMP-preloaded and dip-loaded membranes for guided bone regeneration of rabbit cranial defects.
- Published in:
- Journal of Tissue Engineering & Regenerative Medicine, 2017, v. 11, n. 2, p. 425, doi. 10.1002/term.1926
- By:
- Publication type:
- Article
The bromodomain inhibitor N-methyl pyrrolidone reduced fat accumulation in an ovariectomized rat model.
- Published in:
- Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0209-2
- By:
- Publication type:
- Article